Frontier Capital Management’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-618,821	Closed	-$5.89M	–	278
2022 Q1	$5.89M	Buy	618,821 +462,203	+295%	+$4.4M	0.05%	241
2021 Q4	$2.98M	Buy	+156,618	New	+$2.98M	0.02%	265